Business News • MarketWire • Amedica Announces Receipt of Nasdaq Notice of Bid Price Deficiency

Amedica Announces Receipt of Nasdaq Notice of Bid Price Deficiency

Amedica Announces Receipt of Nasdaq Notice of Bid Price Deficiency

SALT LAKE CITY, UT--(Marketwired - Aug 19, 2016) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that on August 17, 2016, the Company received a letter from the Nasdaq Listings Qualifications department of the Nasdaq Capital Market ("Nasdaq") notifying the Company that the minimum bid price per share for its common stock was below $1.00 for a period of thirty (30) consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

View More : http://www.marketwired.com/mw/release.do?id=2152216&sourceType=3

Releted News by marketwire

For Nearly 100 Years Royal Neighbors has Fought Cancer on Many Fronts

UMED Holdings, Inc. Announces Raise of $1,000,000 to Complete the Funding of the F. Conrad Greer Lab at The University of Texas at Arlington and Construct a Fully Operational Scaled Model Gas-to-Liquids (GTL)

Reda Bedjaoui -- Explains the Effect of Interest Rates on the Stock Market